Jones Hill Capital »

Pharvaris N V shares owned by Jones Hill Capital

Quarter-by-quarter ownership of Pharvaris N V (PHVS) shares owned by Jones Hill Capital from 13F filings

Historical chart of Jones Hill Capital investment in Pharvaris N V

Tip: Access up to 7 years of quarterly data

All positions including Pharvaris N V held by Jones Hill Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Pharvaris N V by Jones Hill Capital

Quarter filed Position value Share count Share price at filing
2026-03-31 $4.7M 167k 28.25

More positions owned by Jones Hill Capital

BioMarin Pharmaceutical (BMRN)
Vertex Pharmaceuticals Incorporated (VRTX)
Vaxcyte (PCVX)
Nuvalent Inc-a (NUVL)
Capricor Therapeutics Com New (CAPR)
Terns Pharmaceuticals (TERN)
Bicara Therapeutics (BCAX)
Biosante Pharmaceuticals (ANIP)
Ultragenyx Pharmaceutical (RARE)
Enliven Therapeutics (ELVN)
Amylyx Pharmaceuticals (AMLX)
Argenx Se Sponsored Adr (ARGX)
Fulcrum Therapeutics (FULC)
Vir Biotechnology (VIR)
Nuvation Bio Com Cl A (NUVB)

View all positions for Jones Hill Capital

Top funds holding Pharvaris N V

General Atlantic
FMR
Foresite Capital Management IV
venBio Partners
Viking Global Investors
EQT Fund Management S.a r.l.
Deerfield Management Company
Bain Capital Life Sciences Investors
Commodore Capital
Wellington Management Company
Novo A/S
Saturn V Capital Management
Point72 Asset Management
Cormorant Asset Management
Sofinnova Ventures

View all funds holding Pharvaris N V